front 1 ADRs are categorized into two types: | back 1 predictable (type A) and unpredictable (type B) |
front 2 Type A reactions are | back 2 dose-dependent, related to the known pharmacologic properties of the drug can occur in any patient and range from mild to severe (most common reaction) |
front 3 Examples of type A reactions | back 3 orthostatic hypotension with doxazosin nephrotoxicity with aminoglycosides |
front 4 Type B reactions are | back 4 not dose-dependent, are unrelated to the pharmacologic actions of the drug and can be influenced by patient-specific factors (genetics) |
front 5 Type B reactions are categorized as | back 5 immediate (occurring within 60 mins after exposure) and delayed (occurring days to months after exposure) |
front 6 Define type I reactions- immediate | back 6 IgE- mediated, ranging from minor local reactions to severe systemic reactions (ex: urticaria, angioedema, anaphylaxis) |
front 7 Define type II reactions- delayed | back 7 antibody-mediated, usually occurring 5-8 days after exposure (ex: hemolytic anemia, thrombocytopenia) |
front 8 Define type III reactions- delayed | back 8 immune-complex reactions, occurring ≥ 1 week after exposure (ex: serum sickness) |
front 9 Define type IV reactions- delayed | back 9 T- cell mediated, occurring 48 hours to weeks after exposure (ex: SJS) |
front 10 Define thrombotic thrombocytopenic purpura | back 10 blood disorder in which clots form throughout the body, the clotting process consumes platelets and leads to bleeding under the kin and the formation purpura (bruises) and petechiae (dots) on the skin |
front 11 SJS and TENS involve | back 11 epidermal detachment and skin loss that is equivalent to third degree burn (generally occur 1-3 weeks after drug exposure) |
front 12 Systemic steroids are contraindicated with | back 12 TEN but may be used for SJS |
front 13 Anaphylaxis treatment includes | back 13 epinephrine injection + diphenhydramine +/- steroids +/- IV fluids |
front 14 Adult dose for epinephrine | back 14 0.3 mg |
front 15 Pediatric dose for epinephrine | back 15 0.15 mg |
front 16 beta-lactams should be avoided with a | back 16 stated allergy to another beta-lactam |
front 17 What monobactam is considered safe in patients with an immediate-type penicillin allergy | back 17 aztreonam |
front 18 Side effects, adverse events and allergies should be reported to the | back 18 FDAs MedWatch program which is called the FDA Adverse Event Reporting System (FAERS) |
front 19 The FDA can required ______ for approved drugs and biologics, to collect and analyze ADR reports and better understand a drug's safety profile | back 19 phase IV trials |
front 20 A boxed warning indicates | back 20 a risk of death or permanent disability |
front 21 Contraindications indicate that | back 21 the drug cannot be used in patient (the risk will outweigh possible benefit) |